Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...
Sortiert nach
Einfacher Volltextzugriff von (fast) überall
Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...
    Datensatz exportieren als...
  • BibTeX
Antitumour activity of enzalutamide (MDV3100) in patients with metastatic castration-resistant prostate cancer (CRPC) pre-treated with docetaxel and abiraterone
European journal of cancer (1990), 2014-01, Vol.50 (1), p.78-84
2014
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
Randomised phase II study of siltuximab (CNTO 328), an anti-IL-6 monoclonal antibody, in combination with mitoxantrone/prednisone versus mitoxantrone/prednisone alone in metastatic castration-resistant prostate cancer
European journal of cancer (1990), 2012-01, Vol.48 (1), p.85-93
2012
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
Molecular alterations and emerging targets in castration resistant prostate cancer
European journal of cancer (1990), 2014-03, Vol.50 (4), p.753-764
2014
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
Effect of abiraterone acetate treatment on the quality of life of patients with metastatic castration-resistant prostate cancer after failure of docetaxel chemotherapy
European journal of cancer (1990), 2013-11, Vol.49 (17), p.3648-3657
2013
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
Effects of metformin and statins on outcomes in men with castration-resistant metastatic prostate cancer: Secondary analysis of COU-AA-301 and COU-AA-302
European journal of cancer (1990), 2022-07, Vol.170, p.296-304
2022
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
Dual inhibition of ErbB1 (EGFR/HER1) and ErbB2 (HER2/neu)
European journal of cancer (1990), 2007-02, Vol.43 (3), p.481-489
2007
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
A phase I study of daily afatinib, an irreversible ErbB family blocker, in combination with weekly paclitaxel in patients with advanced solid tumours
European journal of cancer (1990), 2015-11, Vol.51 (16), p.2275-2284
2015
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
17 The Challenges of Drug Combination Studies
European journal of cancer (1990), 2012-11, Vol.48, p.9-9
2012
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
Multidisciplinary interventions in a specialist Drug Development Unit to improve family history documentation and onward referral of patients with advanced cancer to cancer genetics services
European journal of cancer (1990), 2019-06, Vol.114, p.97-106
2019
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
Clinical outcomes of adolescents and young adults with advanced solid tumours participating in phase I trials
European journal of cancer (1990), 2018-09, Vol.101, p.55-61
2018
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
Management of patients with advanced prostate cancer—metastatic and/or castration-resistant prostate cancer: Report of the Advanced Prostate Cancer Consensus Conference (APCCC) 2022
European journal of cancer (1990), 2023-05, Vol.185, p.178-215
2023
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
Capivasertib in combination with enzalutamide for metastatic castration resistant prostate cancer after docetaxel and abiraterone: Results from the randomized phase II RE-AKT trial
European journal of cancer (1990), 2024-07, Vol.205, p.114103-None, Article 114103
2024
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
AZD8186 study 1: Phase I study to assess the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD) and preliminary anti-tumour activity of AZD8186 in patients with advanced castration-resistant prostate cancer (CRPC), squamous non-small cell lung cancer, triple negative breast cancer and with PTEN-deficient/mutated or PIK3CB mutated/amplified malignancies, as monotherapy and in combination with vistusertib (AZD2014) or abiraterone acetate
European journal of cancer (1990), 2016-12, Vol.69, p.S19-S19
2016
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
Lack of consensus identifies important areas for future clinical research: Advanced Prostate Cancer Consensus Conference (APCCC) 2019 findings
European journal of cancer (1990), 2022-01, Vol.160, p.24-60
2022
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
2571 A high baseline neutrophil count may predict poor prognostic outcome in mCRPC: A post-hoc analysis of the TROPIC phase III trial
European journal of cancer (1990), 2015-09, Vol.51, p.S501-S501
2015
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
An international expanded-access programme of everolimus: Addressing safety and efficacy in patients with metastatic renal cell carcinoma who progress after initial vascular endothelial growth factor receptor-tyrosine kinase inhibitor therapy
European journal of cancer (1990), 2012-02, Vol.48 (3), p.324-332
2012
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
2560 Baseline serum clusterin level in patients with poor prognostic features was associated with response to custirsen treatment: Results from the phase 3 SYNERGY trial of docetaxel +/- custirsen
European journal of cancer (1990), 2015-09, Vol.51, p.S497-S497
2015
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
2578 Neutrophil-to-lymphocyte ratio (NLR) in relation to outcome of castration-resistant prostate cancer (CRPC) patients treated with corticosteroids (CS)
European journal of cancer (1990), 2015-09, Vol.51, p.S504-S504
2015
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
The role of genomic profiling in adolescents and young adults (AYAs) with advanced cancer participating in phase I clinical trials
European journal of cancer (1990), 2018-05, Vol.95, p.20-29
2018
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
2550 Phase Ib study of abiraterone acetate (AA) plus buparlisib (BKM120) or BEZ235 in patients (pts) with castration-resistant prostate cancer (CRPC)
European journal of cancer (1990), 2015-09, Vol.51, p.S493-S493
2015
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
2579 Evaluation of clinical decision-making and the use of circulating tumor cells (CTCs) by physicians treating castration-resistant prostate cancer (CRPC)
European journal of cancer (1990), 2015-09, Vol.51, p.S504-S504
2015
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
90-Days mortality rate in patients treated within the context of a phase-I trial: How should we identify patients who should not go on trial?
European journal of cancer (1990), 2008-07, Vol.44 (11), p.1536-1540
2008
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
2558 Impact of PTEN protein loss on response to docetaxel and overall survival (OS) in metastatic castration resistant prostate cancer (mCRPC) patients
European journal of cancer (1990), 2015-09, Vol.51, p.S496-S496
2015
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
Making sense of antisense
European journal of cancer (1990), 2005-12, Vol.41 (18), p.2812-2818
2005
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
453 Plasma metabolomic signature of novel signal transduction inhibitors from preclinical identification to clinical validation
European journal of cancer (1990), 2014-11, Vol.50, p.148-149
2014
Volltextzugriff (PDF)
1 – 25 von 36
Suche als RSS-Feed
Aktive Filter
Zeitschrift / SerieEuropean Journal Of Cancer
Suchergebnisse filtern
Filter anzeigen